Department of Oncology-Pathology
The Department of Oncology-Pathology conducts basic, translational and clinical research and educational activities related to cancer.
Frontiers in Cancer Research and Therapy
The annual international cancer conference is arranged on the 26th to 27th of March 2020 by the Department of Oncology-Pathology.
New top publication in PNAS from OnkPat
New top publication in PNAS from OnkPat
Christofer Juhlin together with colleagues at Karolinska Institutet, Great Britain and USA including this year's nobel prize winner Dr. WG Kaelin Jr, has published an article in Proceedings of the National Academy of Sciences of the United States of America.
Fertility-sparing surgery is as good as radical surgery for early ovarian cancer
Fertility-sparing surgery is as good as radical surgery for early ovarian cancer
Young women with early stage ovarian cancer can undergo fertility-preserving surgery without affecting the safety of their cancer treatment, Gry Johansen and Kenny Rodriguez-Wallberg from OnkPat report in a national study published in the journal Gynecologic Oncology.
Smaller operational margins just as safe in high-risk melanoma
Smaller operational margins just as safe in high-risk melanoma
Hanna Eriksson and Deborah Utjés from OnkPat have in a multicenter study shown that it is enough with two centimeter margin at surgery for malignant melanoma instead of up to four centimeters which has been used. In the study, published in The Lancet, the researchers has followed over 900 patients for an average span of 19 years.
Prognostic importance of PDL-1 in breast cancer
Theodoros Foukakis with colleagues in Belgium and OnkPat has compiled an analysis of the immuno-checkpoint protein PDL-1 (a target for immunotherapy) and shown that it can predict the prognosis for breast cancer. The results have been published in Clinical Cancer Research.
High impact publication in Lancet Oncology
Hanna Eriksson and Johan Hansson with colleagues in the Netherlands have published an article in Lancet Oncology where they show that it is better to give neoadjuvant immunotherapy to cancer patients before the surgeon removes a tumor instead of afterwards.
Two assistant professorships sponsored by the Swedish Childhood Cancer Fund
Monika Ehnman and Nina Gustafsson Sheppard were granted funding for four years assistant professorships from the Swedish Childhood Cancer Fund.
Grants from Dr Åke Olsson Foundation for Hematological Research 2019
This year four researchers from the Department of Oncology-Pathology will share a grant of 2 000 000 SEK: Isabelle Magalhaes, Jeanette Lundin, Nina Gustafsson Sheppard and Mohammad Hojjat Farsangi.